MedTrace Logo

Identifying Diabetes and Impaired Glucose Tolerance in ICU Patients

NCT07261865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4198

Last updated 2026-05-04

No results posted yet for this study

Summary

In the Netherlands, patients admitted to the ICU are classified as having diabetes based on whether their medical records indicate glucose management medication use (Dutch National Intensive Care Evaluation (NICE) Registry). However, this approach does not identify patients with 1) undiagnosed diabetes, 2) uncontrolled diabetes, 3) patients managing their condition through lifestyle modifications, or 4) individuals with prediabetes, which is considered an early stage of diabetes. Consequently, this may lead to an underestimation of the "true" prevalence of chronic dysglycaemia among ICU patients and as a result the impact of various glycaemic states on acute outcomes remain underexplored.

Conditions

  • Diabetes (DM)
  • Critical Illness

Sponsors & Collaborators

  • Frisius Medisch Centrum

    collaborator OTHER

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Jill Moser, PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07261865 on ClinicalTrials.gov